
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Novotech announced the launch of Novotech SMO Korea Co. Limited in South Korea, expanding its business to include clinical trial site management organization (SMO) services.
Read the full release






